Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
11 studies found for:    Open Studies | "Influenza in Birds"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Influenza in Birds" (11 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Not yet recruiting A Safety and Immunogenicity Study of IVACFLU-A/H5N1
Condition: Avian Influenza
Interventions: Biological: A/H5N1 vaccine;   Biological: Placebo Comparator
2 Not yet recruiting Immunogenicity of Monovalent Inactivated Influenza A/H7N9 Virus Vaccine.
Conditions: Avian Influenza;   H1N1 Influenza;   Influenza
Interventions: Drug: AS03;   Biological: Influenza Virus Vaccine, Monovalent A/H3N2v A/Minnesota/11/2010 NYMC X-203;   Biological: Monovalent influenza A/H7N9 virus vaccine
3 Recruiting A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
Condition: Avian Influenza
Interventions: Drug: MF59;   Biological: Influenza Virus Vaccine, Live Attenuated H7N9 Anhui 2013/AA ca;   Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013
4 Recruiting Safety and Immunogenicity of IVACFLU-A/H5N1 in Vietnamese Adult
Condition: Influenza A/H5N1
Interventions: Biological: IVAC-H5N1-15ug;   Biological: IVAC-H5N1-30ug;   Biological: IVAC-placebo
5 Recruiting Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant
Condition: A/Vietnam/H5N1 Influenza Virus
Interventions: Biological: 7.5 mcg H5N1 (stored as monobulk);   Biological: 15 mcg H5N1 (stored as monobulk);   Biological: 90 mcg H5N1 (stored as monobulk);   Biological: 90 mcg H5N1 (stored in vials);   Other: MF59;   Other: MF59 (stored as monobulk)
6 Recruiting H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
Conditions: Avian Influenza;   Influenza
Interventions: Drug: AS03;   Drug: MF59;   Biological: Monovalent Influenza A/H5N8 vaccine
7 Recruiting Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection
Conditions: Acute Lung Injury;   Acute Respiratory Distress Syndrome (ARDS);   Multiple Organ Failure
Intervention: Drug: Menstrual blood stem cells
8 Recruiting Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in Adults
Conditions: Influenza;   Healthy
Interventions: Biological: Multimeric 001 (M-001);   Biological: H5N1 influenza vaccine;   Biological: Saline
9 Unknown  Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults
Condition: Pandemic Influenza
Intervention: Biological: Pandemic Influenza Vaccine (H5N1)
10 Recruiting A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults
Condition: Influenza
Interventions: Biological: recombinant influenza hemagglutinin;   Biological: Advax1;   Biological: Advax2
11 Recruiting A Dose Ranging Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' GSK1557484A Vaccine in Children 6 to Less Than 36 Months of Age
Condition: Influenza
Intervention: Biological: Influenza A (H5N1) Virus monovalent vaccine (GSK1557484A).

Indicates status has not been verified in more than two years